Keyphrases
Primary Prevention
100%
Renal Transplant Recipients
100%
Photodynamic Therapy
100%
Dysplasia
100%
Randomized Controlled Trial
100%
Actinic Keratosis
44%
Interim Analysis
22%
Organ Transplant Recipients
22%
Blind Test
11%
3-year Follow-up
11%
High Risk
11%
Healthy Skin
11%
Cutaneous Squamous Cell Carcinoma (cSCC)
11%
Forearm
11%
Early Prevention
11%
Delayed Onset
11%
Skin Area
11%
Squamous Cell Carcinoma (SqCC)
11%
Early Treatment
11%
Contralateral Hemisphere
11%
Primary Prophylaxis
11%
Medicine and Dentistry
Dysplasia
100%
Photochemotherapy
100%
Randomized Controlled Trial
100%
Kidney Graft
100%
Primary Prevention
100%
Actinic Keratosis
44%
Interim Analysis
22%
Transplantation
22%
Squamous Cell Carcinoma
11%
Skin Carcinoma
11%
Contralateral
11%
Pharmacology, Toxicology and Pharmaceutical Science
Randomized Controlled Trial
100%
Photodynamic Therapy
100%
Dysplasia
100%
Actinic Keratosis
44%
Squamous Cell Carcinoma
11%
Skin Carcinoma
11%